Your browser doesn't support javascript.
loading
Health care utilization and end-of-life care for older patients with acute myeloid leukemia.
El-Jawahri, Areej R; Abel, Gregory A; Steensma, David P; LeBlanc, Thomas W; Fathi, Amir T; Graubert, Timothy A; DeAngelo, Daniel J; Wadleigh, Martha; Ballen, Karen K; Foster, Julia E; Attar, Eyal C; Amrein, Philip C; Brunner, Andrew M; Stone, Richard M; Temel, Jennifer S.
Afiliação
  • El-Jawahri AR; Department of Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Abel GA; Dana-Farber Cancer Institute, Center for Outcomes and Policy Research, Harvard Medical School, Boston, Massachusetts.
  • Steensma DP; Dana-Farber Cancer Institute, Center for Outcomes and Policy Research, Harvard Medical School, Boston, Massachusetts.
  • LeBlanc TW; Department of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fathi AT; Dana-Farber Cancer Institute, Center for Outcomes and Policy Research, Harvard Medical School, Boston, Massachusetts.
  • Graubert TA; Department of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • DeAngelo DJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
  • Wadleigh M; Department of Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Ballen KK; Dana-Farber Cancer Institute, Center for Outcomes and Policy Research, Harvard Medical School, Boston, Massachusetts.
  • Foster JE; Department of Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Attar EC; Dana-Farber Cancer Institute, Center for Outcomes and Policy Research, Harvard Medical School, Boston, Massachusetts.
  • Amrein PC; Dana-Farber Cancer Institute, Center for Outcomes and Policy Research, Harvard Medical School, Boston, Massachusetts.
  • Brunner AM; Department of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Stone RM; Dana-Farber Cancer Institute, Center for Outcomes and Policy Research, Harvard Medical School, Boston, Massachusetts.
  • Temel JS; Department of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer ; 121(16): 2840-8, 2015 Aug 15.
Article em En | MEDLINE | ID: mdl-25926135
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Assistência Terminal / Leucemia Mieloide Aguda / Aceitação pelo Paciente de Cuidados de Saúde Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Assistência Terminal / Leucemia Mieloide Aguda / Aceitação pelo Paciente de Cuidados de Saúde Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2015 Tipo de documento: Article